CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Head & Neck Cancers
Immunotherapy in GU Cancers
Immunotherapy in Lung Cancer
Immunotherapy in Melanoma
Mantle Cell Lymphoma
Melanoma & Skin Cancer
Oncology Nursing News
Precision Medicine in Oncology
Special Reports in Personalized Cancer Care
SELECT A TOPIC
<< View More Conferences
2018 State of the Science Summit on Genitourinary Cancers
Oncology Conference Multimedia
View more videos >>
Dr. Agarwal on Emerging Immunotherapeutic Combinations in Kidney Cancer
Dr. Yu on the Future of Castration-Sensitive Prostate Cancer
Dr. Yu on Treatment Intensification in Metastatic Castration-Sensitive Prostate Cancer
Oncology Conference Articles
Yu Shares Insight on Recent Advances in Castration-Sensitive Prostate Cancer
Evan Ya-Wen Yu, MD, discusses the evolution of treatment for patients with castration-sensitive prostate cancer and how he decides between treatment with abiraterone and docetaxel for this population.
Localized Bladder Cancer Paradigm Still Faces Obstacles
Brock O’Neil, MD, discusses the struggles with treating localized bladder cancer in both the neoadjuvant and adjuvant settings, as well as the advancements with robotic cystectomy.
Expert Elaborates on Emerging Advances in Bladder Cancer Care
Petros Grivas, MD, PhD, discusses ongoing clinical trials exploring novel approaches with the potential to change practice in advanced bladder cancer
Expert Shares Upfront Sequencing Strategies in mRCC
Sumanta Kumar Pal, MD, sheds light on the latest frontline therapeutic options for patients with mRCC and other advancements on the horizon.
Sequencing Challenges Persist in Metastatic Prostate Cancer
Scott Samuelson, MD, discusses frontline treatment of patients with prostate cancer and subsequent sequencing.
Study Could Resolve Abiraterone/Docetaxel Debate in Hormone-Sensitive Prostate Cancer
Andy Hahn, MD, discusses the ongoing debate between abiraterone and docetaxel and the optimal patient selection for each agent in patients with metastatic hormone-sensitive prostate cancer.
Agarwal Addresses Sequencing Challenges in Kidney Cancer
Neeraj Agarwal, MD, discusses his preferred sequencing strategies for treating patients with kidney cancer, and ongoing immunotherapy research in the field.
FDA Approval in CTCL, Breakthrough Therapy Designation in CRC, and More
Immunotherapy Data Lead Lung Cancer Landscape Following ASCO 2018
Importance of NGS and Targetable Mutations Stressed in AML
Tripathy Discusses Developments in HR+ Breast Cancer
Standards of Care Shifting in Early-Stage NSCLC
Covering Every Angle of Oncology Practice. Click a cover below, to view more.
American Journal of Managed Care
Oncology Nursing News
Physicians' Education Resource
Physician's Money Digest
Specialty Pharmacy Times
Terms & Conditions
2 Clarke Drive
Cranbury, NJ 08512
Copyright OncLive 2006-2018
Intellisphere, LLC. All Rights Reserved.